Praj Industries Ltd Q2 FY2027 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/mudj9rfzgnzl15el8vi9gde4.pdf

Key Takeaways


GenX: The Margin Recovery Engine

Sachin Raole: "That's right, Atul. We can say that." (confirming margins have bottomed out at ~6.2% and unlikely to fall below)

CBG: Policy Tailwind Meets Proven Technology

Ashish Gaikwad: "while there were many players who flocked into this opportunity, it is important to have credibility on technology, and that's what Praj brings in."

Ethanol: Feedstock Shift Creates Retooling Demand

Ashish Gaikwad: "As Indian ethanol producers face such feedstock variation challenges, Praj provides them the required operational flexibility with our proven design, decades of experience, and end-to-end solution and services to deal with this situation."

International & Emerging Verticals

Ashish Gaikwad: "Overall, we remain optimistic, but we don't control the policy, or we don't control the blending mandate. So, we are, therefore, one of the several stakeholders in seeing to it that we get a biofuel which is viable and which can be blended into diesel, because diesel is a large market in India."

Margin Structure & Cost Dynamics


The ₹10,000 Crore Vision: Delayed, Not Derailed

Ashish Gaikwad: "What has happened, though, is some of the inflection points that we have assumed in our journey have been delayed. Those are not something that have got canceled, but those are delayed... our direction and our ambition remains steadfast."

Guidance & Commitments

CommitmentSpecificsTimeline
GenX order bookingManagement expects to be "absolutely right" on previously indicated FY27 numbers; orders to trickle from Q3H2 FY27
GenX PBT breakevenBreakeven on visibility of ₹500–₹600 crore turnoverWithin next 12 months
GenX revenue on top lineRevenue effect visibleQ4 FY27 and onwards
EBITDA margin floorMargins bottomed out at ~6.2%, unlikely to fall belowCurrent levels onward
CBG JV incorporation50/50 JV with BPCL incorporatedNext 2–3 months
CBG JV first plantCommercial production after ~15 months; 8–10 plants over 2–3 years~15 months from JV incorporation
CBG JV ordering opportunityOrdering from JV could materializeOver next 12 months
Greenfield backlog clarityClarity on projects facing sugary-feedstock challengesBy end of FY27
Bio-IBA scale-up demonstrationCommercialization and scale-up demonstrationBeginning of next year
SAF final investment decisionCustomer FID expectedQ1 FY28
International pipelineOpportunity pipeline of ~₹1,000 crore developingOver next few quarters

Key Metrics

MetricQ2 FY27
Consolidated income from operations₹849 crore, compared to ₹842 crore in Q2 FY26
Profit before tax₹36.1 crore, compared to ₹29.6 crore in Q2 FY26
Profit after tax₹23.1 crore, compared to ₹19.2 crore in Q2 FY26
H1 FY27 income from operations₹1,560 crore, compared to ₹1,480 crore in H1 FY26
H1 FY27 profit after tax₹34.7 crore, compared to ₹24.62 crore in H1 FY26
EBITDA margin~6.2% (per an analyst's math)
Export revenue share38% of total revenue
Revenue mix69% Bioenergy, 21% Engineering, 10% PHS
Order intake₹715 crore, 62% domestic and 38% international
Order intake mix57% bioenergy, 26% engineering, 17% PHS
Order backlog₹4,460 crore as of September 2026, 63% domestic
Cash in hand₹533 crore as of September 30, 2026
International opportunity pipeline~₹1,000 crore developing over next few quarters, mainly bioenergy
GenX facility customer approvals18 international customers approved, 4 framework agreements operationalized
GenX data center tie-up$52 million to be delivered over approximately 2.5 years